Mainz Biomed N.V., a public company under Dutch law, held its annual general meeting on June 2, 2025, at the CMS Derks Star Busman N.V. offices in Amsterdam. Chaired by non-executive director Hans Hekland, the meeting included the consideration of the statutory management report for the financial year ending December 31, 2024. All voting items on the agenda were adopted with the requisite majority. The meeting concluded with no further business. Documents related to the meeting, including the agenda with explanatory notes and a tabulation report by Broadridge, are available on the company's website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.